CLINICAL_TRIALS
trial_result
· 2021-10-11
Clinical Trial Update: Sphenopalatine Ganglion Blocks RCT [Phase 4]
Summary
A Phase 4 randomized controlled trial evaluating sphenopalatine ganglion blocks for migraine has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2021-10-11